GUARDIAN: The Social Robot Companion to Support Homecare Nurses
NCT ID: NCT05284292
Last Updated: 2023-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-03-16
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supporting Older Spousal Caregivers Who Care for a Partner With Multimorbidity at Home
NCT06229431
Social Robot Support for Healthcare Professionals
NCT03857789
Effectiveness of a Smart Community- and Home-based Integrated Care Services System for Elderly People
NCT06848036
RoboCare - Technology in Care Homes
NCT05439304
The Presence of Humanoid Robot With Older Adults at Homes
NCT06487611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The GUARDIAN trial involves the enrollment of 10 elderly people in each of the three participant countries (different from those recruited in the Alpha phase) and their respective informal caregivers. The evaluations will be carried out at baseline (T0) and then every month, for three months (T1, T2, T3).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental arm
The Guardian platform consists of the robot Misty II, the Senior App and the Caregiver App will be tested by the elderly subjects together with their caregivers
GUARDIAN platform
The enrolled elderly subjects and their caregivers will use at home the GUARDIAN platform consists of the Senior App, the Caregiver App and the Misty II robot.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GUARDIAN platform
The enrolled elderly subjects and their caregivers will use at home the GUARDIAN platform consists of the Senior App, the Caregiver App and the Misty II robot.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an informal caregiver
* Healthy sight and hearing
Exclusion Criteria
* Lack of informal caregivers
* Sight and hearing not intact
* Lack of informed consent
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Commission
OTHER
Istituto Nazionale di Ricovero e Cura per Anziani
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Irccs Inrca
Ancona, , Italy
Hospital St Jansdal
Harderwijk, , Netherlands
Hôpitaux Universitaires de Genève
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Margaritini A, Benadduci M, Amabili G, Bonfigli AR, Luzi R, Wac K, Nap HH, Maranesi E, Bevilacqua R. The social robot companion to support homecare nurses: The guardian study protocol. Contemp Clin Trials Commun. 2022 Oct 30;30:101024. doi: 10.1016/j.conctc.2022.101024. eCollection 2022 Dec.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INRCA_001_2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.